Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

(iStock)
October 26, 2017

Study to test combination therapy for breast cancer

Vanderbilt-Ingram Cancer Center (VICC) has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer.

By VUMC News and Communications
October 26, 2017

My Cancer Genome launches new search tool for clinical trials

Clinicians, investigators and cancer patients now have access to a new online search tool that provides more detailed information about clinical research trials available for cancer patients.

By VUMC News and Communications
October 25, 2017

Vanderbilt-Ingram Cancer Center patients treated with new FDA-approved CAR-T therapy

Vanderbilt-Ingram Cancer Center has been selected as one of the few authorized treatment centers in the United States approved to administer the first FDA- approved chimeric antigen receptor T cell (CAR-T) therapy for treatment of adult patients with a specific type of lymphoma. VICC is the only cancer center in a seven-state region of the Southeast authorized to deliver the new immunotherapy.

By VUMC News and Communications
October 19, 2017

Symposium honors Moses’ storied cancer research career

Members of the Vanderbilt University Medical Center (VUMC) community and others whose lives and careers have been influenced by legendary cancer investigator, educator and administrator Harold (Hal) Moses, M.D., have endowed the Linda and Harold L. Moses, M.D. Career Development Fund.

By VUMC News and Communications
October 18, 2017

Calcium intake and colorectal cancer

Calcium intake appears to protect against colorectal cancer in individuals with certain gene variants, Vanderbilt researchers have discovered.

By Leigh MacMillan
October 17, 2017

Researchers find novel mechanism of resistance to anti-cancer drugs

Vanderbilt investigators have discovered a novel non-genetic cause of resistance to the targeted anti-cancer therapy cetuximab. Their findings, reported this week in Nature Medicine, suggest a strategy for overcoming this resistance.

By Leigh MacMillan
October 6, 2017

The world beyond work: Lynetha Verge

She loves “Beauty and the Beast” and Disney World. Mornings—not so much.
By Dagny Stuart
September 28, 2017

VICC investigators land support from Komen Foundation

Three breast cancer investigators from Vanderbilt-Ingram Cancer Center (VICC) have been awarded research grants from Susan G. Komen, a nonprofit foundation devoted to supporting cancer research, community health outreach, advocacy and public policy initiatives.
By VUMC News and Communications
September 21, 2017

Special symposium to honor Moses’ cancer research contributions is Oct. 11

A research symposium honoring the career of Harold (Hal) Moses, M.D., who founded and served as director emeritus of Vanderbilt-Ingram Cancer Center, has been slated for Wednesday, Oct. 11, 7:45 a.m. – 3:30 p.m., at the Vanderbilt Student Life Center.
By VUMC News and Communications
September 14, 2017

Acid reflux cancer link

Blocking acid reflux-induced production of reactive oxygen compounds may be a useful strategy for preventing DNA damage and decreasing the risk of esophageal cancer.
By Sanjay Mishra
September 14, 2017

Film documents photographer’s journey to regain quality of life

Nashville photographer Fred Dusel took a long draw on his ever-present trademark cigar as he studied a richly detailed carbon transfer print of wind-twisted driftwood on a barrier island beach in Georgia.
By Jill Clendening
September 13, 2017

Chic Awearness event supports VUMC ovarian cancer research

The annual Chic Awearness fundraising event that supports ovarian cancer research at major medical centers, including Vanderbilt University Medical Center (VUMC), will be held Monday, Sept. 25, 6:30 – 8:30 p.m., at Prima Restaurant, 700 12th Ave. South.
By VUMC News and Communications
September 8, 2017

VICC launches creative writing class focused on cancer journey

Vanderbilt-Ingram Cancer Center (VICC) is offering an expressive writing course for cancer patients and others who have been affected by the disease. This year’s “Express Yourself: Fall Creative Writing Series” is provided to anyone interested in learning about expressive writing, and participants will have the opportunity to create original writing in a safe, supportive environment.
By VUMC News and Communications
1 … 25 26 27 28 29 … 55